EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cellular and tissue-based skin substitutes for diabetic foot ulcers

Yenny Elers Mastrapa, Fabian Quiroz Zendejas

SAP Podiatry · 2026-08-13 · 3 · 267

DOI: 10.62486/pod2026267 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Diabetic foot ulcers heal slowly and precede most diabetes-related lower limb amputations. Cellular and tissue-based skin substitutes are used when standard care fails, but their effect on complete healing remains uncertain. Methods: This systematic review followed PRISMA 2020. Scopus, PubMed, OpenAlex and Crossref were searched from 2018 to 2026 for randomized controlled trials and comparative studies comparing a cellular or tissue-based skin substitute with standard care, placebo or another substitute in adults with diabetic foot ulcers. Results: Of 414 records identified, 307 were screened and 11 randomized controlled trials were included. Of five trials with a standard-care comparator, intact fish skin graft achieved healing in 44% versus 26% at 16 weeks, ovine forestomach matrix in 46% versus 24% at 12 weeks, and dehydrated amnion-chorion in 50% versus 17%; one large cryopreserved amniotic trial found no significant difference (66.1% versus 59.8%). Conclusions: Cellular and tissue-based skin substitutes increased complete healing of diabetic foot ulcers in most included trials, although the evidence is limited by small samples, open designs and clinical heterogeneity.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →